COMMUNIQUÉS West-GlobeNewswire
-
Sweetwater Brewing Unveils Modern Rebrand
25/04/2024 - 13:00 -
Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension
25/04/2024 - 13:00 -
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
25/04/2024 - 13:01 -
Streamline Health® Signs Second Enterprise Client
25/04/2024 - 13:30 -
Jushi Holdings Inc. to Report First Quarter 2024 Financial Results on May 9, 2024
25/04/2024 - 13:30 -
Kura Oncology to Report First Quarter 2024 Financial Results
25/04/2024 - 13:30 -
XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
25/04/2024 - 13:30 -
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
25/04/2024 - 07:30 -
Communiqué de presse : Sanofi réitère ses objectifs financiers pour 2024, après une forte croissance de 7% portée par les lancements
25/04/2024 - 07:30 -
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
25/04/2024 - 07:30 -
Crossject communique ses résultats financiers audités pour 2023
25/04/2024 - 07:32 -
Crossject reports audited financial results for 2023
25/04/2024 - 07:32 -
Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update
25/04/2024 - 08:00 -
deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024
25/04/2024 - 09:00 -
Less than half of veterinary professionals feel their profession is appreciated
25/04/2024 - 09:00 -
Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
25/04/2024 - 07:00 -
Merus annonce les résumés acceptés pour présentation à la réunion annuelle 2024 de l’ASCO
25/04/2024 - 01:54 -
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
25/04/2024 - 04:11 -
STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024
24/04/2024 - 22:30
Pages